Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites - PubMed (original) (raw)
- PMID: 7182348
- DOI: 10.1007/BF02796382
Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites
W H Chen et al. In Vitro. 1982 Jan.
Abstract
A human pancreatic tumor cell line has been established from the ascites of a patient with histopathologically confirmed adenocarcinoma of the head of the pancreas and maintained for more than 12 months in the laboratory. Epithelioid tumor cell colonies, which resulted from primary tissue cultures of the ascitic cell component, were mechanically isolated by needle micromanipulation. Tumorigenicity was proven in athymic nude mice. Morphologically the pancreatic tumor epithelial cells grew to confluency with moderately tight adhesion to the culture plastic surface and with free-floating cells in the medium. Upon re-establishment of the tumoral xenograft in tissue culture, the epithelial cells retained their original morphology. Histologically the tumor grown in nude mice exhibited prototypic characteristics of the primary adenocarcinoma in the patient, producing abundant mucin and displaying a broad spectrum of glandular differentiation, which ranged from well to poorly differentiated adenocarcinomas with occasionally localized lymphocytic infiltrations. Furthermore, the tumor expressed carcinoembryonic antigen and human pancreas cancer associated antigen. This tumor line, designated AsPC-1, has been cultured for at least 10 passages in vitro and 3 in vivo. It represents a new model for human pancreatic cancer.
Similar articles
- Characterization of a new primary human pancreatic tumor line.
Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, Pickren JW, Berjian R, Douglass HO Jr, Chu TM. Tan MH, et al. Cancer Invest. 1986;4(1):15-23. doi: 10.3109/07357908609039823. Cancer Invest. 1986. PMID: 3754176 - [Establishment and characterization of human pancreatic adenocarcinoma cell line JHP-1 producing carbohydrate antigen 19-9 and carcinoembryonic antigen].
Sujino H, Nagamori S, Fujise K, Hasumura S, Homma S, Matsuura T, Shimizu K, Niiya M, Kameda H. Sujino H, et al. Hum Cell. 1988 Jun;1(2):250-5. Hum Cell. 1988. PMID: 2979202 Japanese. - Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse.
Kyriazis AP, McCombs WB 3rd, Sandberg AA, Kyriazis AA, Sloane NH, Lepera R. Kyriazis AP, et al. Cancer Res. 1983 Sep;43(9):4393-401. Cancer Res. 1983. PMID: 6871872
Cited by
- GATA4 Regulates Inflammation-Driven Pancreatic Ductal Adenocarcinoma Progression.
Jiang W, Chen C, Huang L, Shen J, Yang L. Jiang W, et al. Front Cell Dev Biol. 2021 Apr 29;9:640391. doi: 10.3389/fcell.2021.640391. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33996796 Free PMC article. Retracted. - Uncovering the role of FXYD3 as a potential oncogene and early biomarker in pancreatic cancer.
Yee KX, Lee YC, Nguyen HD, Chen MY, Ni YC, Wu YF, Lee KH. Yee KX, et al. Am J Cancer Res. 2024 Sep 15;14(9):4353-4366. doi: 10.62347/LUDE7524. eCollection 2024. Am J Cancer Res. 2024. PMID: 39417182 Free PMC article. - Pharmacokinetics in Mouse and Comparative Effects of Frondosides in Pancreatic Cancer.
Al Shemaili J, Parekh KA, Newman RA, Hellman B, Woodward C, Adem A, Collin P, Adrian TE. Al Shemaili J, et al. Mar Drugs. 2016 Jun 17;14(6):115. doi: 10.3390/md14060115. Mar Drugs. 2016. PMID: 27322291 Free PMC article. - Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction.
Butz J, Wickstrom E, Edwards J. Butz J, et al. BMC Biotechnol. 2003 Jul 23;3:11. doi: 10.1186/1472-6750-3-11. Epub 2003 Jul 23. BMC Biotechnol. 2003. PMID: 12877750 Free PMC article. - Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumors.
Santamaria S, Delgado M, Botas M, Castellano E, Corraliza-Gorjon I, Lafuente P, Muñoz-Calleja C, Toribio ML, Kremer L, Garcia-Sanz JA. Santamaria S, et al. Front Immunol. 2022 Jul 27;13:825635. doi: 10.3389/fimmu.2022.825635. eCollection 2022. Front Immunol. 2022. PMID: 35967322 Free PMC article.
References
- Cancer Res. 1976 Sep;36(9 PT 2):3486-94 - PubMed
- Prog Clin Biol Res. 1980;37:115-32 - PubMed
- J Natl Cancer Inst. 1981 Sep;67(3):563-9 - PubMed
- Int J Cancer. 1980 May 15;25(5):591-8 - PubMed
- Br J Cancer. 1978 Feb;37(2):261-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials